UTICA, N.Y.— ConMed Corp. (NYSE: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents a share for the first quarter. The dividend is payable on April 5 to all shareholders of record as of March 15. ConMed manufactures surgical devices and equipment for […]
UTICA, N.Y.— ConMed Corp. (NYSE: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents a share for the first quarter.
The dividend is payable on April 5 to all shareholders of record as of March 15.
ConMed manufactures surgical devices and equipment for minimally invasive procedures. The firm’s products are used by surgeons and physicians in specialties that include orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
ConMed reported net sales of $862.5 million in 2020, down 9.7 percent from $955 million in 2019. The company said on Jan. 27 that it expects full-year 2021 revenue between $975 million and $1.02 billion.
